Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 1, 1999, Pages 34-38

  Robles, Robert ^a   Lugo, Denise ^a   Gee, Lauren ^b   Jacobson, Mark A ^a,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ward 84 ^*  (United States)

Author keywords

Antiretroviral drugs; Cytomegalovirus; Kaposi's sarcoma

Indexed keywords

CD4 ANTIGEN; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0032954465     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199901010-00005     Document Type: Article

References (18)

1. Freidman-Kien A, Laubenstein L, Marmor M, et al. Kaposi's sarcoma and pneumocystis among homosexual men: New York City and California. MMWR Morb Mortal Wkly Rep 1981;30:305-8.
2. Peterman T, Jaffe H, Freidman-Kien A, Weiss R. The aetiology of Kaposi's sarcoma. Cancer Surv 1991;1:23-37.
3. Chang Y, Cesarman E, Pessin MS. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
4. Moore PS, Chang Y. KSHV sequences identified in KS specimens from all varieties of Kaposi's Sarcoma. N Engl J Med 1995;332: 1181-5.
5. Jones J, Hanson D, Chu S, et al. AIDS-associated Kaposi's sarcoma. Science 1995;267:1078-9.
6. Costagliola D, Mary-Krause M. Can antiviral agents decrease the occurrence of Kaposi's's sarcoma? Lancet 1995;346:578.
7. Mocroft A, Youle K, Gazzard B, et al. Anti-herpesvirus treatment and risk of Kaposi's's sarcoma in HIV infection. AIDS 1996;10: 1101-5.
8. Martin D, Kuppermann B. Wolitz R, et al. Combined oral ganciclovir and intravitreal ganciclovir implant for treatment of patients with cytomegalovirus retinitis: a randomized, controlled study [abstract #LB-9]. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada, 1997.
9. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994;26:749-52.
10. Studies of Ocular Complications of AIDS Research Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.
11. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV in-fection. N Engl J Med 1995;332:1181-5.
12. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
13. Mocarski ES. Propagating Kaposi's sarcoma-associated herpesvirus [editorial]. N Engl J Med 1997;336:214-5.
14. Kedes DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997;99: 2082-6.
15. Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997;11:1327-32.
16. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
17. Bais C, Santomasso B, Coso O, et al. KSHV/HHV-8 G protein-coupled receptor is a viral oncogene and angiogenesis activator [abstract no. 527]. 5th Conference on Retroviruses and Opportunistic Infections, 1998, Chicago, Illinois, U.S.A..
18. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 1996;173:1477-80.